OSTEOARTHRITIS KNEE
Clinical trials for OSTEOARTHRITIS KNEE explained in plain language.
Never miss a new study
Get alerted when new OSTEOARTHRITIS KNEE trials appear
Sign up with your email to follow new studies for OSTEOARTHRITIS KNEE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Knee osteoarthritis drug trial ends early: what we learned
Disease control TerminatedThis study tested a drug called lorecivivint for people with knee osteoarthritis over two years. It included 276 adults who had already been in a previous study. The goal was to see if the drug could safely reduce pain and improve knee function. The trial was stopped early, so re…
Matched conditions: OSTEOARTHRITIS KNEE
Phase: PHASE3 • Sponsor: Biosplice Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 06:43 UTC
-
Weight loss showdown: surgery vs. diet before joint replacement
Disease control TerminatedThis study looked at whether bariatric surgery or medical weight loss is better at helping severely obese patients lose enough weight to safely have hip or knee replacement surgery. The goal was to get patients to a body mass index (BMI) of 40 or lower. The study was stopped earl…
Matched conditions: OSTEOARTHRITIS KNEE
Phase: NA • Sponsor: Boston Medical Center • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New knee pain drug shows promise in early trial
Symptom relief TerminatedThis study tested an experimental drug called GSK3858279 in 314 adults with moderate to severe knee osteoarthritis pain. The goal was to find the safest and most effective dose to reduce pain. The study was terminated early, but results may still help guide future research.
Matched conditions: OSTEOARTHRITIS KNEE
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated May 26, 2026 06:54 UTC
-
Knee pain drug trial halted early – what happened?
Symptom relief TerminatedThis study tested an experimental drug called QUC398 in 101 people with painful knee osteoarthritis. The goal was to see if it could reduce pain and protect knee cartilage. The trial was stopped early, so results are limited.
Matched conditions: OSTEOARTHRITIS KNEE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 26, 2026 06:52 UTC
-
Tiny nerve zapper eases knee pain without surgery?
Symptom relief TerminatedThis study tested a temporary device that stimulates nerves around the knee to relieve chronic pain from osteoarthritis. Twelve adults with knee pain received the treatment, and researchers measured changes in pain intensity and quality of life. The goal was to see if this non-su…
Matched conditions: OSTEOARTHRITIS KNEE
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC
-
Which X-Ray best spots knee arthritis? study seeks answer
Knowledge-focused TerminatedThis study looked at different X-ray methods and MRI to see which best shows cartilage loss in arthritic knees. Researchers aimed to help doctors decide if patients need partial or full knee replacement. The study was stopped early with only 8 participants, so results are limited…
Matched conditions: OSTEOARTHRITIS KNEE
Phase: NA • Sponsor: Oxford University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
Can the 'Love Hormone' ease arthritis pain? small study investigates
Knowledge-focused TerminatedThis study looked at whether oxytocin, a natural hormone, can reduce pain when given through an IV. It included 7 people—some healthy and some with severe knee arthritis. Researchers measured pain from a heated skin patch to see how oxytocin changes pain perception.
Matched conditions: OSTEOARTHRITIS KNEE
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC